“I believed in the power of PhysioPD when I first saw it twenty-five years ago, I’ve had a passion for it ever since, and now we have enough experience that I know it works.”
About Rosa & Co
Rosa was founded in 2002 and remains an employee-owned, science-focused, and client-friendly firm. Today, Rosa is the worldwide commercial leader in PhysioPD-style Research, with comprehensive basic biology and therapeutic experience, industry-leading modeling expertise, and repeat research engagements with a majority of the Top 20 pharmaceutical companies.
Rosa Market Modeling, which offers a credible methodology for determining expected physician uptake for healthcare products, was started by Bill Brastow, Ph.D., in 2005. Our models have helped shape first-in-class markets including novel therapy combinations for HIV and molecular diagnostic tests for Oncology.
Rosa’s staff bring more than a century of aggregate experience in applying modeling to the inherent challenges faced by drug developers and have authored hundreds of scientific posters, conference presentations, relevant patents, and peer-reviewed publications.
Rosa Leadership in the Community
Host Worldwide Webinar Series: Impact of Modeling & Simulation in Drug DevelopmentPresentations from the pharmaceutical industry, academia, and regulatory agencies
International Society of PharmacometricsChair of the QSP Special Interest Group
Co-Chair of the Variability, Uncertainty, and Error in QSP Models Working Group
Co-Chair of the Integrating QSP and Machine Learning Working Group
Member of the Immuno-Oncology Working Group
Former Member of the QSP Workflows and Methodologies Working Group
Former Chair of the QSP in Regulatory Interactions Working Group
Former Secretary of the QSP SIG
Member of the International Consortium for Innovation & Quality in Pharmaceutical Development Clinical Pharmacology Leadership Group QSP Working Group
Strategic Cooperation Agreement with MathWorks®, provider of MATLAB®, and SimBiology®
NEWTON, MA – July 8, 2020 – Acer Therapeutics Announces Administration of ACER-001 in a Fasted State Increased Systemic Exposure of Phenylbutyrate in Healthy Volunteer Food Effect Study Model suggests ACER-001, Acer’s taste-masked, immediate-release ... Read More
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today the publication of an article entitled “Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu rece... Read More
Today, Rosa & Co. announced that Dr. Bill Brastow, Chief Technology Officer at Rosa Market Modeling, will present a webinar entitled “Driving Market Share for Healthcare Products by Integrating Market Modeling” on Wednesday, March 18. Hosted in p... Read More
Today, Rosa & Co. announced that Dr. Vincent Hurez, Senior Scientist at Rosa & Co., will present a webinar entitled “Predicting subjective or complex clinical outcomes in QSP models: challenges and approaches” on Wednesday, May 12th.As part o... Read More
ACoP119-13 Nov, 2020https://www.go-acop.org/Virtual
Virtual Quantitative Systems Pharmacology Week 2020Aug. 24-28, 2020Virtual
Drug Research and Development for Adults Across the Older Age Span5-6 Aug, 2020https://www.nationalacademies.org/event/08-05-2020/drug-research-and-development-for-older-adult-populations-a-workshopVirtual